
Advaxis Inc. is devoted to the discovery, development, and commercialization of immunotherapies based on a technology platform which uses engineered Listeria monocytogenes. The company is headquartered in Monmouth Junction, New Jersey.
GlobalSubmit eCTD ソフトの詳細はお気軽にお問い合わせください。
サターラはGlobalSubmit eCTD ソフトウェアと 薬事規制業務 & eCTD専門チームが協力し、貴社の効率的かつ期限内の提出を支援します。Custom partnership models that range from eCTD software solutions for submission management to full-fledged regulatory operations support are available to add capabilities and capacity for our clients.

お問合せはこちら